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Vaccine design using Bioinformatics software 775vaccine development. Addition our newly designed systemic analysis method to supplement
the WHO guidelines could accelerate the development of urgently needed vaccines that might
concurrently combat several strains of viruses within a shorter period.
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Influenza virus contains hemagglutinin (HA) and neuramin-
idase (NA), which were coded as H and N strands, respec-
tively. These H and N strands represent different strains of
the virus.1e3 Generally, immune response loci of HA and NA
were used for designing vaccines. The standard World
Health Organization procedure for vaccine development4e6
has provided a guideline for influenza viruses, but no sys-
tematic operational model.4
We recently designed a systemic analysis method to
evaluate annual perspective sequence changes of influenza
virus strains, and found a better way to design and accel-
erate the development of vaccines that can be used to
combat several viral strains at the same time. This new
procedure of vaccine development would reduce at least
3e6 weeks from the standard processing procedure of the
World Health Organization.4 Our design can help scientists
shorten the time of blind tests and be a better method for
producing vaccines against unknown strains of influenza
virus based on previously known flu vaccines.
Our methods could rapidly identify similarity among
strains and localize the closest strains. When a new strain
of virus is confirmed for disease manifestation, we can
instantaneously find the closest pre-made vaccine by whole
sequence matching with NeedlemaneWunsch (NeW) dy-
namic programming to identify the common and reserved
antigenic areas. In fact, at the International Engineering
Invention and Innovation Exhibition (Malaysia) in March
2013, using the same combinatorial methods, we had pre-
dicted that H7N9 could be derived from H7N7; these se-
quences of the isolated virus were later reported by Lam
et al.7
In this study, we use the same method to analyze se-
quences of influenza viruses that are most devastating to
humans, and plan to develop bioinformatic methods to
consolidate the predicting consistency and reliability of our
model. By such biological methods, we might be able to
quantitatively produce vaccines without compromising
their effectiveness against lethal viruses.
Materials and methods
Analysis programs
In this study, we applied the unweighted pair group method
with arithmetic mean (UPGMA),1,8e10 maximum likelihood
estimate (MLE),11 and NeW dynamic programming12 to
evaluate evolutional changes and relationship between vi-
ruses in polymerase basic 2 (PB2) and NA, respectively. Two
evolution analysis software, dnaml of PHYLIP 3.6913 and
ClustalX2,10 were used to show the phylogenetic pedigreesamong viruses based on the results of MLE and UPGMA,
respectively.
Sequences of influenza viruses
The genetic sequences of H1N1 (GenBank: GQ132185.1),
H1N2 (GenBank: AY129157.1), H2N2 (GenBank: DQ508
843.1), H3N2 (GenBank: U71142.1), H3N8 (GenBank: KF79
0582.1), H5N1 (GenBank: AF509095.1), H5N2 (GenBank:
AY300929.1), H5N3 (GenBank: AY207510.1), H7N1 (Gen-
Bank: AY207538.1), H7N2 (GenBank: CY037097.2), H7N3
(GenBank: CY076858.1), H7N7 (GenBank: CY133723.1),
H7N9 (GenBank: KF420298.1), and H10N7 (GenBank:
CY157240.1) had been collected from the databases of the
National Center for Biotechnology Information.
Analysis of immune loci
We applied ClustalX2 and dynamic programming to analyze
the different bases (immune loci) between those 14 NA
sequences.
Results
To analyze the relationships among various influenza vi-
ruses, we collected genetic sequences of H1N1, H1N2,
H2N2, H3N2, H3N8, H5N1, H5N2, H5N3, H7N1, H7N2, H7N3,
H7N7, and H10N7 from the databases of National Center for
Biotechnology Information. Moreover, an influenza virus
contains eight nucleic acid fragments that encode 11 pro-
teins, namely PB2, PB2-F1, PB1, PA, HA, NP, NA, M1, M2,
NS1, and NS2.9,14 The sequence of PB2 reveals the evolu-
tionary origin of a virus and has often been used in phylo-
genetic analysis.2,3,7,14 Therefore, the MLE method was
used to determine phylogenetic pedigrees of PB2 sequences
among viruses. Results showed that H5N3 had the most
evolutionary relationship with H7N3, and there was also
high similarity between H7N7, H7N9, and H7N2 (Fig. 1A).
The NA gene of an influenza virus encodes a surface
protein that is essential for releasing progeny virions from
the infected cell surface and prevent self-aggregation.15
Thus, the NA has been targeted to design antiviral drugs.
In fact, the NA inhibitor is one of the two major classes of
antivirals licensed and effectively limits the severity of viral
infections.15 Therefore, we further investigated the NA
section of the 14 viruses by UPGMA. In Figs. 1B and 1C, we
found that PB2 analysis could be extrapolated to those for
NA.
Annual production of influenza virus vaccines was based
on historical records used to predict the future prevalence
of the disease.4 However, the error in prediction of influ-
enza virus mutant is inevitable. For example, the lack of a
Figure 1 (A) Rootless tree diagram analysis of PB2 of influenza viruses. NA (UPGMA) (B) rooted (B) or (C) rootless tree diagram of 14 viruses prior to using NeW dynamic
programming to all-sequence comparison. NA (UPGMA) (D) rooted or (E) rootless tree diagram of 14 viruses after using NeW dynamic programming to all-sequence comparison.
NA Z neuraminidase; NeW Z NeedlemaneWunsch; UPGMA Z unweighted pair group method with arithmetic mean.
776
Y.-J.
H
u
e
t
a
l.
Figure 2 NA (MLE) (A) rooted or (B) rootless tree diagram of 14 viruses after using NeW dynamic programming to all-sequence comparison. (C and D) NA all-sequence comparison
and immune loci analysis of 14 viruses. MLE Z maximum likelihood estimate; NA Z neuraminidase; NeW Z NeedlemaneWunsch.
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778 Y.-J. Hu et al.framework for modeling nucleotide insertions/deletions
together with nucleotide substitutions would also lead to an
error in phylogenetic analysis. To avoid such conditions,
multiple alignments of NA were constructed based on the
complete nucleotide sequences, using the NeW dynamic
programming and then UPGMA for precise calculation and
cross-examination (Figs. 1D and 1E).
To reduce an arithmetic error in the calculation of
phylogenetic diversity, we also applied NeW dynamic pro-
gramming and MLE to evaluate the relationships between
14 viruses in NA sequences (Figs. 2A and 2B). The result
showed that there was no difference between UPGMA and
MLE calculations (Figs. 1D and 2A, and Figs. 1E and 2B,
respectively).
To find the basic difference between those 14 influenza
viruses for the determination of immune loci, we further
conducted a continuous analysis of NA sequences by NeW
dynamic programming and MLE. We used H7N9 and H5N3
sequences. The total length of H7N9 sequence was 1426
base pairs and that of H5N3 was 1422 base pairs. After
calculation, H7N9 was found to have 623 loci of immune
response, and 43.32% of blind tests could be reduced. The
number of loci of immune response of H5N3 was 191, and
reduction in blind tests was 13.55% (Figs. 2C and 2D).
Discussion
Previously available biomedical information is used for
vaccine development; however, in this case, the major
problems would be to predict the correct future viral
strains that can cause widespread infection and the
possible viral mutations that may influence the presenta-
tion of effective epitopes to provoke protective immune
responses.16 Projection of the best epitopes is particularly
important for influenza viruses, which from time to time
become lethal to human beings. Moreover, because of the
distinctive features of RNA viruses, persistent gene muta-
tions as well as possible genome recombination and reas-
sortments are inevitable, which by contrast, could generate
more deadly strains to cross species barrier, leading to
more widespread manifestation.
In this study, we have developed a novel method by
combining UPGMA,1,8,9 MLE, and NeW dynamic program-
ming12 to define the annually detected mutational changes.
We used these annual results to determine mutational
ranges and the most probable mutation sites in the gene,
which could then be used to project by using computer
analysis the coming unknown virus which would be the
major target for production of the vaccine.12
In this way, there are many uncertainty products of
vaccines which could be eliminated. The derivation of
statistical outcomes is shown in Figs. 1De2D. We could not
only identify the relationship as well as subtle differences
between known viruses, but also pinpoint the most plau-
sible immune loci for biochemical experiments to raise
effective antibodies (Figs. 2C and 2D). In addition, our re-
sults could be further extrapolated to the drug design; for
instance, the current design of antiviral drugs was focused
primarily on NA, such as oseltamivir and zanamivir, both of
which are NA inhibitors.6 However, our results have shown
that HAs can be the next potential target, similar to NAs.Moreover, our previous study had been awarded by the
2013 International Biochemical Technology Invention. The
patent rightsof thisnewmethods for vaccinedevelopmentare
under application via Intellectual Property Rights (IPR) Center
of National Chung Hsing University, Taichung, Taiwan (patent
numbers: 102134134 and 103111788)9 and the USA (patent
number: 14/482,506). This study could effectively improve
the current reversed genetics procedure of vaccine develop-
ment (Figs. 2C and 2D). As the best epitopes to provoke
appropriate immunity couldbe identified faster, 3e6weeks of
developing time could be saved. The cost of vaccine devel-
opment can also be reduced markedly. It also helps medical
policy making and provides more protections for peoples.References
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